Services
We are a clinical-stage biotechnology company researching and developing novel antibody therapies, with a focus on improving outcomes for people living with autoimmune and inflammatory diseases.
Therapeutic research
Discovery and optimisation of novel antibody candidates.
Preclinical development
Rigorous preclinical study to establish safety and mechanism.
Clinical programs
Carefully designed trials that test our candidates in patients.
Scientific partnerships
Collaborating with researchers and institutions to move science forward.
Not sure which you need?
Describe your situation and we will point you to the right option — or tell you if it is not something we do.